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Viral attachment to the host cell is critical for tissue
and species specificity of virus infections. Recently,
pattern of viral attachment (PVA) in human respira-
tory tract was determined for highly pathogenic avian
influenza virus of subtype H5N1. However, PVA of
human influenza viruses and other avian influenza
viruses in either humans or experimental animals is
unknown. Therefore, we compared PVA of two hu-
man influenza viruses (H1N1 and H3N2) and two low
pathogenic avian influenza viruses (H5N9 and H6N1)
with that of H5N1 virus in respiratory tract tissues of
humans, mice, ferrets, cynomolgus macaques, cats,
and pigs by virus histochemistry. We found that hu-
man influenza viruses attached more strongly to hu-
man trachea and bronchi than H5N1 virus and at-
tached to different cell types than H5N1 virus. These
differences correspond to primary diagnoses of tra-
cheobronchitis for human influenza viruses and diffuse
alveolar damage for H5N1 virus. The PVA of low patho-
genic avian influenza viruses in human respiratory tract
resembled that of H5N1 virus, demonstrating that other
properties determine its pathogenicity for humans. The
PVA in human respiratory tract most closely mirrored
that in ferrets and pigs for human influenza viruses
and that in ferrets, pigs, and cats for avian influenza
viruses. (Am J Pathol 2007, 171:1215–1223; DOI:
10.2353/ajpath.2007.070248)
Infections with human influenza A viruses of the subtypes
H1N1 and H3N2 are important causes of respiratory tract
disease. The most common lesion in immunocompetent
individuals is tracheobronchitis.1 Uncommonly, human
influenza A virus infection causes severe pneumonia,
which requires hospitalization and may be fatal. This
pattern of disease contrasts with the ongoing outbreak of
highly pathogenic avian influenza A virus infection of the
subtype H5N1. In this outbreak, severe pneumonia is the
most common lesion in the 300 patients with confirmed
H5N1 virus infection, and the case fatality rate is over
50% (World Health Organization http://www.who.int/csr/
disease/avian_influenza/country/cases_table_2007_06_04/
en/index.html). Until now, there is no evidence that this
avian virus has become efficiently transmissible among
humans, which could result in a new pandemic.2
The increased interest in H5N1 virus infection has
highlighted large gaps in our knowledge of the patho-
genesis of influenza A virus infections in humans. An
important factor in this pathogenesis is tissue tropism,
which depends largely on the ability of the virus to
attach to the host cell.3 Influenza A viruses attach to
host cells by binding of the hemagglutinin (HA) protein
to sialosaccharides on the host cell surface. The HAs
of influenza A viruses from different host species differ
in their specificity of binding. For example, HAs of
human influenza A viruses preferentially recognize
sialic acid (SA)--2,6-Gal-terminated saccharides (-
2,6-SA), whereas HAs of avian influenza viruses pref-
erentially recognize SA--2,3-Gal-terminated saccha-
rides (-2,3-SA).4–6 These differences generally correspond
with the variation in the type of SAs expressed at impor-
tant sites for influenza A virus replication in the respective
host species. For example, human tracheal epithelium
expresses mainly -2,6-SA,7 whereas duck intestinal ep-
ithelium expresses mainly -2,3-SA.8 Therefore, the type
and distribution of SA is considered to be an important
factor in the susceptibility of different host species to
influenza A viruses.9 The SA recognized by influenza A
virus is not only important in the host species range but
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also in its transmissibility. The latter was demonstrated in
experimental infections of ferrets with the 1918 pandemic
influenza virus. In this study, horizontal transmission was
abolished by two amino acid mutations in the HA that
caused a switch in binding preference from human
-2,6-SA to avian -2,3-SA.10
A traditional method for studying the tissue tropism
of different influenza A viruses is to measure the dis-
tribution of SAs by use of lectin histochemistry. Lectin
histochemistry makes use of the property of a wide
variety of lectins to specifically bind to SAs.11 Studies
on receptors for influenza virus have made use of the
plant lectins Sambucus nigra agglutinin, which has a
major specificity for -2,6-SA, and Maackia amurensis
agglutinin, which has a major specificity for -2,3-
SA.12,13 Although useful for determining the distribu-
tion of SAs in tissues, these lectin histochemistry tech-
niques are only an indirect measure of influenza A virus
attachment to host tissues. They do not account for
other variables that influence the binding specificity.
For HA, these include glycosylation and sialylation
close to the receptor binding site5; for the receptor,
these include type of SA, alternative linkages,14 and sulfa-
tion and fucosylation of the saccharide residues.15
To circumvent these problems, we made use of virus
histochemistry to study the pattern of virus attachment
(PVA) in respiratory tissues. This method, modified from
Couceiro et al,7 directly displays the attachment of influ-
enza virus to tissues. By use of this method, we recently
determined that H5N1 virus attachment in the human
respiratory tract is progressively more abundant toward
the alveoli, where the virus attaches predominantly to
type II pneumocytes and alveolar macrophages.16 This
attachment pattern fits with the limited pathology data on
H5N1 virus infection in humans, which show diffuse alve-
olar damage as the primary lesion.17–19 Our results on
H5N1 virus were supported by recent experimental stud-
ies in human ex vivo lung cultures, which demonstrated
H5N1 virus replication in the lower respiratory tract
(LRT).13,20
Although limited studies have been done on the
human trachea,7 the PVA for human influenza A viruses
in the LRT is not known. This information is important to
understand better the pathogenesis of influenza pneu-
monia, which is centered on the LRT. In addition, it is
not clear whether the PVA of H5N1 virus that we ob-
served is unique among avian influenza viruses and
therefore may in part explain its ability to cause respi-
ratory disease in humans. Finally, the PVA of human
influenza A virus in experimental animals is not known.
This information is important to help select the most
appropriate animal model for influenza pneumonia. Of
particular interest is the domestic pig, which is permis-
sive for both human and avian influenza A virus infec-
tions and may thus act as a “mixing vessel” for the
generation of reassortant viruses.21 Therefore, we here
describe the PVA of two currently circulating subtypes
of human influenza A virus (H3N2 and H1N1) and low
pathogenic avian influenza viruses (H5N9 and H6N1)
to compare these with the PVA of highly pathogenic
avian influenza A virus H5N1 in human respiratory
tract. Furthermore, we determined the PVA of these
human and avian influenza A viruses in respiratory
tract of known experimental animals.
Materials and Methods
Experimental Design
To determine the PVA of human and avian influenza A
viruses in the trachea and LRT of humans, we used two
low pathogenic avian influenza viruses (H5N9 and
H6N1), a highly pathogenic avian influenza A virus H5N1
isolate, and two recently circulating human influenza vi-
ruses (H3N2 and H1N1). We determined whether attach-
ment occurred to epithelial cells in the trachea or LRT
(including bronchi, bronchioles, and alveoli) and to alve-
olar macrophages.
The PVA of all of the above viruses was also deter-
mined in mammalian species, which are used for exper-
imental influenza A virus infections. Animals included
were cynomolgus macaque (Macaca fascicularis), Euro-
pean shorthair cat, ferret, Yorkshire-Landrace pig, and
C57/BL6 mouse.
Viruses
Influenza virus A/Netherlands/35/05 (H1N1) and A/Neth-
erlands/213/03 (H3N2) are recent human isolates grown
on Madin-Darby canine kidney cells and were kindly
provided by the National Influenza Center (Rotterdam,
The Netherlands). Influenza virus A/Mallard/Sweden/
79/02 (H5N9) and A/Mallard/Sweden/81/02 (H6N1) were
obtained from cloacal swabs of migratory mallard ducks
(Anas platyrhynchos) during ongoing influenza virus sur-
veillance of wild birds and were subsequently passaged
twice in embryonated hens’ eggs.22 Influenza virus
A/Vietnam/1194/04 (H5N1) was isolated from a fatal hu-
man case. The virus was kindly provided by Dr. W. Lim
(Queen Mary Hospital, Hong Kong, People’s Republic of
China), and propagated once in Madin-Darby canine
kidney cells.
Virus Preparation, Inactivation, and Labeling
The H1N1, H3N2, and H5N1 viruses, isolated from hu-
mans, were grown in Madin-Darby canine kidney cells.
The supernatant was harvested and cleared by low-
speed centrifugation. The H5N9 and H6N1 viruses, iso-
lated from mallards, were grown in the allantoic cavity of
11-day-old embryonated hens’ eggs. The allantoic fluid
was harvested after 2 days and cleared by low-speed
centrifugation. Cleared supernatants and allantoic fluid
samples were subsequently centrifuged 2 hours at
85,000  g in a SW28 rotor at 4°C. The virus pellet was
resuspended in 2 ml of phosphate-buffered saline (PBS),
loaded on a 20 to 60% sucrose (w/w) gradient, and
centrifuged overnight at 300,000  g in a SW41 rotor at
4°C. To deplete the sucrose, the viruses were additionally
centrifuged 2 hours at 85,000  g in a SW28 rotor at 4°C,
and the virus was resuspended in PBS.
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H5N1 virus was inactivated by dialyzing against 0.1%
formalin for 3 days. All other viruses were inactivated by
incubation with 1:1 (v/v) 10% formalin for 1 hour at room
temperature. After inactivation, virus suspensions were
dialyzed against PBS. Inactivation was confirmed by fail-
ure to passage on Madin-Darby canine kidney cells.
Viruses were labeled by mixing concentrated, inacti-
vated viruses, suspended in PBS, with an equal volume
of 0.1 mg/ml fluorescein isothiocyanate (FITC) (Sigma, St.
Louis, MO) in 0.5 mol/L bicarbonate buffer (pH 9.5) for 1
hour with constant stirring. To lose all unbound FITC,
labeled viruses were dialyzed against PBS. To check for
the continued capacity for hemagglutination by the inac-
tivated viruses, the hemagglutination titer of the viruses
was determined after formalin inactivation and FITC
labeling.23
Respiratory Tract Tissues from Humans and
Animals
Archival paraffin-embedded human tissue sections were
obtained from the Department of Pathology, Erasmus
MC. Archival paraffin-embedded animal tissue sections
were obtained from the Department of Virology, Erasmus
MC, or from the Department of Pathobiology, Faculty of
Veterinary Medicine, University of Utrecht (Utrecht, The
Netherlands). All tissues selected were from individuals
without histological lesions or evidence of respiratory
tract infection at the time of death. Three individuals per
species were analyzed.
Virus Histochemistry on Tissue Sections
Formalin-fixed paraffin-embedded tissues were depar-
affinized with xylene and hydrated using graded alco-
hols. FITC-labeled influenza viruses were incubated
overnight at 4°C at a titer of 50 to 100 hemagglutinating
units/50 l. For the visualization by light miscroscopy,
FITC label was detected with a peroxidase-labeled rabbit-
anti-FITC (Dako, Glostrup, Denmark). The signal was am-
plified with a tyramide signal amplification system (Perkin
Elmer, Boston, MA) according to the instructions of the
manufacturer. Peroxidase was revealed with 3-amino-9-
ethyl-carbazole (Sigma), resulting in a bright red precip-
itate. Tissues were counterstained with hematoxylin and
embedded in glycerol-gelatin (Merck, Darmstadt, Ger-
many). Attachment of influenza virus to tissues was visi-
ble as granular to diffuse red staining on the apical sur-
face of epithelial cells. Cytoplasmic staining in epithelial
cells and staining of other cell types was seen occasion-
ally. For each tissue tested, in each run, an omission
control was included to check for nonspecific
amplification.
To validate the method, we incubated labeled H5N1
virus and H3N2 virus with human trachea and mallard
duck intestine. The pattern of attachment of both viruses
to these tissues was as expected. H5N1 virus, which has
retained a preference for -2,3-SA,15 bound abundantly
to duck intestinal epithelium, which expresses mainly
-2,3-SA,8 and bound rarely to human tracheal epithe-
lium, which expresses mainly -2,6-SA.7 In contrast,
H3N2 virus, which has a preference for -2,6-SA, bound
abundantly to human tracheal epithelium and bound
poorly to duck intestinal epithelium.
Double Staining for H5N1 Virus Attachment and
Type II Pneumocytes
H5N1 virus attachment in human lung was detected as
described above, but peroxidase was not yet revealed.
Type II pneumocytes were detected by incubation with a
monoclonal mouse anti-human surfactant apoprotein A
(PSP-A) antibody (Dako) for 1 hour at room temperature,
followed by incubation with an alkaline phosphatase-
labeled goat anti-mouse IgG2b (Southern Biotechnology
Associates, Inc., Birmingham, AL) for 1 hour at room
temperature. Peroxidase was revealed as described
above, and alkaline phosphatase was revealed with
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazo-
lium substrate system (Dako), resulting in a dark blue
precipitate. Sections were not counterstained. Omission
of H5N1 virus or an IgG2b isotype control (instead of
mouse anti-human PSP-A) was included as a negative
control in each run.
Results
Attachment of Human Influenza A Viruses to
Human Respiratory Tract
The human influenza A viruses H3N2 and H1N1 had a
similar PVA to the human respiratory tract (Table 1; Figure
1). Virus attachment in the trachea and bronchi was more
abundant than in the bronchioles. In trachea, bronchi,
and bronchioles, virus predominantly attached to the sur-
face of ciliated epithelial cells, occasionally attached to
goblet cells, and rarely attached to bronchiolar noncili-
ated cuboidal cells. In alveoli, virus attached more to type
I than to type II pneumocytes and very rarely to alveolar
macrophages.
Attachment of Avian Influenza Viruses to Human
Respiratory Tract
The avian influenza viruses H5N9 and H6N1 showed a
similar PVA to tissues of the human respiratory tract that
also resembled the PVA of H5N1 virus (Table 1; Figure 1).
Attachment to the apical cell membrane was usually
granular for H6N1 virus and more diffuse for H5N9 virus.
In contrast to the human influenza A viruses, attachment
of the avian influenza viruses was rare in the trachea and
increased progressively toward the bronchioles. The
avian influenza viruses also preferentially attached to
different cell types than the human influenza A viruses: to
acinar cells of the tracheal and bronchial submucosal
glands (Figure 2) and to mucus at these sites, to noncili-
ated cuboidal cells in the bronchioles, and to type II
pneumocytes and alveolar macrophages in the alveoli.
To confirm that avian influenza viruses attached to type II
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pneumocytes, human lung tissue was double stained
with H5N1 virus and PSP-A, which is a surfactant pro-
duced specifically by type II pneumocytes (Figure 3).
Attachment of Human Influenza A Viruses to
Experimental Animal Respiratory Tract
The PVA of human influenza A viruses to respiratory tract
tissues of some experimental animal species resembled
that of humans more than others (Table 1; Figures 2, 4,
and 5). The PVA of ferrets and pigs resembled that of
humans most closely, because they were the only two
species in which the viruses attached to the surface of
ciliated epithelial cells in the airways and to type I pneu-
mocytes in alveoli. In ferrets, there also was virus attach-
ment to submucosal glands and mucus (Figure 2). In
mice, there was no attachment to trachea, bronchi, or
bronchioles and only occasional attachment to alveolar
epithelial cells of indeterminate type. In macaques and
cats, virus attachment was not observed or was rarely
observed at any level of the respiratory tract.
Attachment of Avian Influenza Viruses to
Experimental Animal Respiratory Tract
The PVA of H5N9 and H6N1 viruses to respiratory tract
tissues resembled that of H5N1 virus in each of the five
animal species (Table 1). As for human influenza A
viruses, the PVA of avian influenza viruses to respira-
tory tract tissues of some animal species resembled
that of humans more than others. The PVA of cats,
ferrets, and pigs (Figure 5) resembled that of humans
most closely, with rare virus attachment in the trachea
and bronchi, rare to occasional attachment to noncili-
ated cuboidal cells in the bronchioles, and predomi-
nant attachment to type II pneumocytes in the alveoli.
In cats, there also was virus attachment to alveolar
macrophages, as in humans. The PVA of macaques
also resembled that of humans, except that virus at-
tachment was predominantly to type I instead of type II
pneumocytes, although attachment to type II pneumo-
cytes was also observed. In mice, virus attachment
was most abundant in the trachea and became pro-
gressively weaker toward the alveoli, which was oppo-
Table 1. Virus Attachment in Respiratory Tract of Humans and Five Animal Species
Virus Species










H3N2 Human † cil † cil  cil  Type I
Mouse    
Ferret * cil *   Type I
Macaque    
Pig † cil † cil  cil  Type I
Cat    
H1N1 Human † cil † cil  cil  Type I
Mouse    
Ferret * cil * cil   Type I
Macaque    
Pig † cil † cil  cil  Type I
Cat    
H5N1 Human * * cil  non-cil ‡ Type II
Mouse  Both  non-cil  non-cil  Type II
Ferret     Type II
Macaque     Type I
Pig     Type II
Cat    non-cil ‡ Type II
H5N9 Human * * cil  non-cil ‡ Type II
Mouse  Both  non-cil  non-cil  Type II
Ferret    
Macaque    
Pig    
Cat    ‡ Type II
H6N1 Human * *  non-cil ‡ Type II
Mouse  Both  non-cil  non-cil 
Ferret     Type II
Macaque     Type I
Pig     Type II
Cat    non-cil ‡ Type II
The mean abundance of cells to which virus attached was scored as follows: , no attachment; , attachment to rare or few cells; , attachment
to a moderate number of cells; , attachment to many cells. Where possible, the predominant cell type to which virus attached is indicated: ciliated
cells (cil), nonciliated cuboidal cell (non-cil), type I pneumocytes (type I), or type II pneumocytes (type II).
*Submucosal glands positive.
†Goblet cells occasionally positive.
‡Alveolar macrophages positive.
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site to the PVA in humans. However, virus attachment
to submucosal glands in mice mirrored that in humans
(Figure 2).
Discussion
This study shows for the first time the PVA of human
influenza A viruses in the human respiratory tract, from
the trachea down to the alveoli. This information is impor-
tant to understand better the pathogenesis of influenza
pneumonia. The PVA of these viruses differs markedly
from that of an H5N1 strain.16 These differences may
explain, at least in part, the contrasts in localization and
severity of respiratory disease between these virus infec-
tions in humans.
The common presentation of human influenza A virus
infection is tracheobronchitis, which fits with the abun-
dant attachment of these viruses to tracheal and bron-
chial epithelium (Table 1; Figure 1). Although rarely, hu-
man influenza A viruses can cause severe pneumonia.
This fits with the ability of human influenza A viruses to
attach to the human LRT. The difference in disease out-
come between human influenza A viruses and H5N1
virus infection, where the primary lesion is severe pneu-
monia,24 fits with differences in virus attachment in the
alveoli. Human influenza A viruses attached primarily to
type I pneumocytes (Table 1; Figure 1), which are less
numerous than type II pneumocytes (40 versus 60% of
alveolar epithelial cells)25 and have low metabolic activ-
ity.26 We therefore speculate that if attachment leads to
infection, virus production by type I pneumocytes is rel-
atively low and can more easily be controlled by the host
innate immune response. In addition, a large proportion
of the human population has serum IgG antibodies
against human influenza A viruses because of prior ex-
posure. Although IgA is important for the protection of the
respiratory tract from nose to bronchi, IgG is the main
antibody involved in protecting the lung from pneumonia.
These IgG antibodies are known to protect the richly
vascularized lung parenchyma from infection and thus
from development of severe pneumonia.27–29
The two low pathogenic avian influenza viruses, H5N9
and H6N1, had a similar PVA to human respiratory tract to
that of H5N1 virus (Table 1; Figure 1), even though low
pathogenic avian influenza viruses rarely infect or cause
disease in humans.30,31 This means that the ability of
H5N1 virus to attach to human respiratory tract cells—
although necessary—is not sufficient to explain the ability
of this virus to induce severe disease in humans. Alter-
native explanations for the uniqueness of H5N1 virus
Figure 1. Attachment of human (H3N2 and H1N1) and avian (highly pathogenic H5N1 and low pathogenic H5N9 and H6N1) influenza viruses in human trachea,
lower respiratory tract (bronchus, bronchiole, and alveoli), and alveolar macrophages.
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among avian influenza viruses may be its ability to repli-
cate efficiently in human respiratory tract cells,20,32 to
induce pro-inflammatory cytokine production,32–35 or to
inhibit the host’s innate immune response.36
The respiratory tract of ferrets and pigs most closely
resembled that of humans with regard to PVA of human
influenza A viruses (Table 1; Figures 4 and 5). This cor-
responds with the permissiveness of pig37,38 and ferret39
for infection with nonadapted isolates of human influenza
A viruses. As in humans, ferrets infected with human
H3N2 virus usually develop upper respiratory tract dis-
ease and occasionally bronchitis and pneumonia,39,40
with similar histological changes as in human disease
and expression of influenza virus antigen in ciliated epi-
thelial cells of bronchi and bronchioles.41 Attachment of
human influenza A virus to ciliated epithelial cells in the
ferret trachea has been observed before.42 The PVA of
human influenza A viruses in respiratory tracts of mouse,
cynomolgus macaque, and cat differed strongly from that
in human respiratory tract, with no attachment to trachea,
bronchus, or bronchioles (Table 1; Figure 4). This fits with
the results of experimental infections. Mice are not per-
missive for nonadapted human influenza A viruses.43
Cynomolgus macaques could be infected experimentally
with human H3N2 virus, but no clinical signs were ob-
served.44 In a recent study, we were unable to show
experimental infection in domestic cats with a human
H3N2 virus, although the same protocol resulted in pro-
ductive infection of H5N1 virus.45
The respiratory tract of cats, ferrets, and pigs most
closely resembled that of humans with regards to PVA of
Figure 2. Attachment of H3N2 virus and H5N1 virus to the submucosal
glands in human, mouse, and ferret trachea.
Figure 3. Confirmation of H5N1 virus attachment to type II pneumocytes in
human alveoli by staining for human surfactant apoprotein A (PSP-A). H5N1
virus attachment is visible as red staining on the apical cell surface, whereas
PSP-A expression, characteristic for type II pneumocytes, is visible as diffuse
dark blue staining in the cytoplasm.
Figure 4. Attachment of H3N2 virus to the trachea and alveoli of human,
mouse, ferret, macaque, and cat.
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avian influenza viruses (Table 1). For cats and ferrets, the
PVA of H5N1 virus to respiratory tract tissues has been
reported previously.16 However, a species not reported
on previously is the pig. Although -2,3-SA (the preferred
receptors of avian influenza viruses) and -2,6-SA (the
preferred receptors of human influenza A viruses) have
been detected in pig trachea by lectin histochemistry,8
only human influenza A viruses attached to pig trachea in
our study (Figure 5; Table 1). Pigs can be infected by
human and avian influenza A viruses, and reassortant
viruses have been isolated from pigs.46 Therefore, pigs
have traditionally been considered as potential mixing
vessels for avian and human influenza A viruses, from
which pandemic influenza viruses may develop.21 How-
ever, reassortment of two influenza A viruses requires
infection of the same host cell. Because our study indi-
cates that such a reassortant is unlikely to occur in tra-
cheal epithelium, it raises the question of where in the
porcine respiratory tract do such reassortments occur.
The PVA of avian influenza viruses, including H5N1
virus, in experimental animals corresponds overall to the
localization of respiratory tract disease reported for ex-
perimental H5N1 virus infection in these species. In
cats,45 ferrets,47 macaques,48 and pigs,49 the lesions are
most severe in alveoli and bronchioles, whereas bronchi
and trachea are less or not affected. This fits with the PVA
of H5N1 virus in these species, which is predominantly in
alveoli and bronchioles (Table 1). In contrast, mice in-
fected with H5N1 virus show substantial necrotizing le-
sions in trachea and bronchi in addition to alveolar and
bronchiolar involvement.50,51 This corresponds to the
moderate to abundant attachment of H5N1 virus to
mouse trachea and bronchus (Table 1).
Tracheobronchial submucosal glands play two poten-
tially opposite roles in influenza virus infection. On the
one hand, they produce mucus that can inactivate virus
and thus inhibit viral infection. On the other hand, the
glands themselves may become infected with influenza
virus, thus enhancing viral infection. In humans, tracheal
submucosal glands produce a different sialosaccharide
(-2,3-SA) from that predominantly expressed by tra-
cheal epithelial cells (-2,6-SA).52 This fits with our at-
tachment study, where avian influenza viruses bound to
human submucosal gland cells and their mucus, but
human influenza viruses did not (Figure 2). This mucus
could trap these avian viruses and result in their expul-
sion by the mucociliary pathway before they can reach
the LRT.52 This fits with the low transmission rate of avian
influenza viruses (both low and highly pathogenic) from
birds to humans30 and of H5N1 virus among humans.24
However, it is inconsistent with the observation that hu-
man H3N2 virus can replicate in human submucosal
glands.53 The only species in which we detected attach-
ment of human H3N2 influenza virus to tracheobronchial
submucosal glands was the ferret (Figure 2), in which
human H3N2 virus also has been shown to replicate in
these glands.54 A possible explanation is that attachment
of H3N2 virus to tracheobronchial submucosal gland is
below the detection limit of our test for humans and above
the limit for ferrets.
Together, the results of this virus attachment study
improve our understanding of the pathogenesis of human
respiratory tract disease from both human and avian
influenza A virus infection. This information on virus at-
tachment needs to be combined with studies on other
factors that may contribute to pathogenicity of influenza A
virus infection, such as replication rate,32,55 escape
mechanisms from innate immune response,56 and induc-
tion of cytokine production.32 Virus attachment studies
also may help in the choice of animal model to study
disease mechanisms and to test preventive and thera-
peutic strategies against both human and avian influ-
enza. The viral histochemistry technique used here for
influenza A virus also may be useful in the research of
other viral diseases.
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